Temporal trends of influenza A (H1N1) virus Seroprevalence following 2009 pandemic wave in Guangdong, China: Three cross-sectional serology surveys

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Yang, Fen ^a   He, Jianfeng ^a   Zhong, Haojie ^a   Ke, Changwen ^a   Zhang, Xin ^a   Hong, Teng ^a   Ni, Hanzhong ^a   Lin, Jinyan ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CHILD; CHINA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; POPULATION RESEARCH; PRESCHOOL CHILD; RECURRENCE RISK; RURAL AREA; SCHOOL CHILD; SEASONAL INFLUENZA; SEROLOGY; SEROPREVALENCE; SUMMER; URBAN AREA; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84862496048     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038768     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (2009) Swine influenza A (H1N1) infection in two children-southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 58: 400 402.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605 2615.
3. WHO (2009) Influenza-like illness in the United States and Mexico. Available: http://www.who.int/csr/don/2009_04_24/en/index.html. Accessed 2009 Feb 24.
4. WHO (2009) Current WHO phase of pandemic alert for Pandemic (H1N1) 2009. Available:http://www.who.int/csr/disease/swineflu/phase/en/. Accessed 2009 Jun 11.
5. Jianfeng H, Haojie Z, Zhengmin Z, Fen Y, Linghui L, (2010) Characteristics of pandemic influenza A(H1N1) in Guangdong Province, 2009. South China J Prev Med 36: 4 8.
6. Cohen J, Enserink M, (2009) After delays, WHO agrees: the 2009 pandemic has begun. Science 324: 1496 1497.
7. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, (2009) Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 15: 2004 2007.
8. Ross T, Zimmer S, Burke D, Crevar C, Carter D, (2010) Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr Influenza, RRN1148.
9. Lipsitch M, Hayden FG, Cowling BJ, Leung GM, (2009) How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 374: 1209 1211.
10. Joseph T, Edward S, Cheuk K, Daniel K, Po-Lai H, (2010) The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong. Clin Infect Dis 51: 1184 1191.
11. Edwin DK, (2006) Influenza Pandemics of the 20th Century. Emerg Infect Dis 12: 9 14.
12. WHO (2010) In focus: H1N1 now in the post-pandemic period. Available: http://www.who.int/csr/disease/swineflu/en/. Accessed 2010 Sept.
13. WHO (2010) Director-General statement following the seventh meeting of the Emergency Committee. Available: http://www.who.int/csr/disease/swineflu/7th_meeting_ihr/en/. Accessed 2010 Feb 24.
14. Deng AP, He JF, Kang M, Zhang X, Ni HZ, (2008) Epidemiologic characteristics of influenza in Guangdong Province, 2005emiologic characteristiev Med 34: 14 17.
15. Lohr SL, (2002) Sampling: design and analysis. Beijing: Chinese Statistical Express.
16. Xu CL, Bai T, Danielle L, Wang M, Yang L, (2011) The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China. PLoS ONE 6: 1 9.
17. Grund S, Adams O, Wahlisch S, Schweiger B, (2011) Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J Virol Methods 171: 369 373.
18. Wang M, Yuan J, Li TG, Liu Y, Wu JB, (2011) Antibody Dynamics of 2009 Influenza A (H1N1) Virus in infected Patients and Vaccinated People in China. PLoS ONE 6: 1 4.
19. Yi ZS, Chao B, Ke X, Wei BH, Tong YW, (2010) Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine. PLoS ONE 5: 1 6.
20. Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, (2009) Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 375: 56 66.
21. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100 1108.
22. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW, (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immuno 199: 117 121.
23. Hancock K, Veguilla V, Lu X, Zhong WM, Butler EN, (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945 1952.
24. Centers for Disease Control and Prevention (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58: 521 524.
25. Chen HL, Wang Y, Liu W, Zhang JX, Dong BQ, (2009) Serologic Survey of Pandemic (H1N1) 2009 Virus, Guangxi Province, China. Emerg Infect Dis 15: 1849 1850.